LTBR acts as a novel immune checkpoint of tumor-associated macrophages for cancer immunotherapy.
Wang L, Fan J, Wu S, Cheng S, Zhao J, Fan F, Gao C, Qiao R, Sheng Q, Hu Y, Zhang Y, Liu P, Jiao Z, Wei T, Lei J, Chen Y, Qin H.
Wang L, et al. Among authors: qiao r.
Imeta. 2024 Sep 4;3(5):e233. doi: 10.1002/imt2.233. eCollection 2024 Oct.
Imeta. 2024.
PMID: 39429877
Free PMC article.